Latest News & Updates

Breaking News

  • 1 day ago

  • Vaibhavi M.

FDA and M-CERSI Launch Two-Day Workshop to Accelerate Pediatric SLE Drug Development in 2026
Breaking News
Teva Launches AHZANTIVE Biosimilar Across Europe Following EMA Approval for Eye Disease

Vaibhavi M.

Other trending news you may like to read

FDA and M-CERSI Launch Two-Day Workshop to Accelerate Pediatric SLE Drug Development in 2026

FDA and M-CERSI host a July 2026 workshop on pediatric SLE extrapolation strategies, signaling evolving expectations for sponsors in autoimmune indications.

Vaibhavi M.

Pharma Now

Teva Launches AHZANTIVE Biosimilar Across Europe Following EMA Approval for Eye Disease

Teva launches AHZANTIVE biosimilar in Europe, targeting ophthalmic biologics where manufacturing complexity has limited biosimilar competition.

Vaibhavi M.

Pharma Now

Intas Pharma Appoints Muthukumar Anbalagan as General Manager for NDDS Division

Intas Pharma appoints Muthukumar Anbalagan as GM–NDDS, signalling a strategic push into complex formulations for regulated markets.

Vaibhavi M.

Pharma Now

Bayer's Finerenone Shows Efficacy Signal Beyond Diabetic CKD in Emerging Trial Data

Finerenone's clinical profile may extend beyond diabetic CKD, with implications for sNDA strategy and commercial-scale manufacturing planning.

Vaibhavi M.

Pharma Now